1983
DOI: 10.1135/cccc19833567
|View full text |Cite
|
Sign up to set email alerts
|

Heterocycles with a pyrido[3,2-e]-1,3-selenazine and pyrido[3,4-e]-1,3-selenazine ring systems

Abstract: 2-Chloronicotinoyl isoselenocyanate (IIa) and 2,6-dimethyl-4-chloronicotinoyl isoselenocyanate (IIb) react with arylamines to give 2-arylimino-4-oxopyrido[3,2-e]-1,3-selenazines IV and 2-arylimino-5,7-dimethyl-4-oxopyrido[3,4-e]-1,3-selenazines V. A reaction of IIa,b with sodium hydrogen sulfide and hydroselenide afford the respective 2-thio- and 2-seleno-4-oxopyrido-1,3-selenazines VI and VII. Structure of these new types of heterocycles was corroborated by spectral (IR, UV, 1H NMR, 13C NMR, and mass) means.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

1984
1984
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…The general structure of the designed compounds is depicted in Figure 2, with carbo-and hetero-cyclic moieties (in blue) and variability on aniline substitution (in green). The proposed synthesis of these compounds was similar to the protocols reported previously for analogous compounds [43,[53][54][55]. Keeping all this previous experience in mind, in this work, we planned the design of a new library of forty seven acylselenoureas with both a potential anticancer and antioxidant activity following a fragment-based approach for drug design [48], varying the two sides of the molecule, searching for a synergistic effect between the fragments and the acylselenourea itself.…”
Section: Introductionmentioning
confidence: 95%
See 1 more Smart Citation
“…The general structure of the designed compounds is depicted in Figure 2, with carbo-and hetero-cyclic moieties (in blue) and variability on aniline substitution (in green). The proposed synthesis of these compounds was similar to the protocols reported previously for analogous compounds [43,[53][54][55]. Keeping all this previous experience in mind, in this work, we planned the design of a new library of forty seven acylselenoureas with both a potential anticancer and antioxidant activity following a fragment-based approach for drug design [48], varying the two sides of the molecule, searching for a synergistic effect between the fragments and the acylselenourea itself.…”
Section: Introductionmentioning
confidence: 95%
“…The general structure of the designed compounds is depicted in Figure 2, with carbo-and hetero-cyclic moieties (in blue) and variability on aniline substitution (in green). The proposed synthesis of these compounds was similar to the protocols reported previously for analogous compounds [43,[53][54][55]. The dose-and time-dependent radical scavenging activity of all of the synthesized compounds were assessed in vitro using the colorimetric assays of 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS).…”
Section: Introductionmentioning
confidence: 99%
“…The reaction of allenyl isoselenocyanate with seleno-containing nucleophiles gave selenazoles 56 (Scheme 31) [27]. The reaction of 20 and 21 with sodium hydroselenide afforded the respective 2-selenoxo-4-oxopyrido-1,3-selenazines 57 and 58 (Scheme 32) [35]. 1,3-Selenazines and 1,3-selenzoles have been prepared from isoselenocyanates via diselenocarbamate intermediates [56].…”
mentioning
confidence: 99%